GB9819898D0 - New vaccine and method of use - Google Patents

New vaccine and method of use

Info

Publication number
GB9819898D0
GB9819898D0 GB9819898A GB9819898A GB9819898D0 GB 9819898 D0 GB9819898 D0 GB 9819898D0 GB 9819898 A GB9819898 A GB 9819898A GB 9819898 A GB9819898 A GB 9819898A GB 9819898 D0 GB9819898 D0 GB 9819898D0
Authority
GB
United Kingdom
Prior art keywords
new vaccine
vaccine
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB9819898A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10838766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB9819898(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB9819898A priority Critical patent/GB9819898D0/en
Publication of GB9819898D0 publication Critical patent/GB9819898D0/en
Priority to NZ51042599A priority patent/NZ510425A/xx
Priority to CNA2007101469740A priority patent/CN101130070A/zh
Priority to AT99969034T priority patent/ATE392214T1/de
Priority to KR1020017003161A priority patent/KR100777896B1/ko
Priority to SI9931008T priority patent/SI1109574T1/sl
Priority to HK01108911.8A priority patent/HK1037978B/en
Priority to EP99969034A priority patent/EP1109574B1/en
Priority to TR200100948T priority patent/TR200100948T2/xx
Priority to IL14184399A priority patent/IL141843A0/xx
Priority to PCT/EP1999/006623 priority patent/WO2000015255A1/en
Priority to ES99969034T priority patent/ES2304068T3/es
Priority to JP2000569839A priority patent/JP2002524532A/ja
Priority to CA 2343399 priority patent/CA2343399C/en
Priority to CN99813127A priority patent/CN1325311A/zh
Priority to CZ20010887A priority patent/CZ302808B6/cs
Priority to DE1999638555 priority patent/DE69938555T2/de
Priority to PL346651A priority patent/PL199545B1/pl
Priority to AU59752/99A priority patent/AU744989B2/en
Priority to BR9913630A priority patent/BR9913630A/pt
Priority to PT99969034T priority patent/PT1109574E/pt
Priority to DK99969034T priority patent/DK1109574T3/da
Priority to HU0104297A priority patent/HUP0104297A3/hu
Priority to ARP990104534 priority patent/AR021798A1/es
Priority to MYPI99003916A priority patent/MY122216A/en
Priority to CO99057608A priority patent/CO5090882A1/es
Priority to TW88115828A priority patent/TWI225790B/zh
Priority to NO20011193A priority patent/NO329522B1/no
Priority to ZA200101987A priority patent/ZA200101987B/en
Priority to US10/760,938 priority patent/US20040151734A1/en
Priority to US11/158,652 priority patent/US20050238659A1/en
Priority to CY081100643T priority patent/CY1108147T1/el
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GB9819898A 1998-09-11 1998-09-11 New vaccine and method of use Ceased GB9819898D0 (en)

Priority Applications (32)

Application Number Priority Date Filing Date Title
GB9819898A GB9819898D0 (en) 1998-09-11 1998-09-11 New vaccine and method of use
DK99969034T DK1109574T3 (da) 1998-09-11 1999-09-08 Vaccine mod seksuelt overförte sygdomme
HU0104297A HUP0104297A3 (en) 1998-09-11 1999-09-08 Vaccine against sexually transmitted diseases
CZ20010887A CZ302808B6 (cs) 1998-09-11 1999-09-08 Vakcína proti sexuálne prenosným nemocem
DE1999638555 DE69938555T2 (de) 1998-09-11 1999-09-08 Impfstoff gegen geschlechtlich übertragene krankheiten
AT99969034T ATE392214T1 (de) 1998-09-11 1999-09-08 Impfstoff gegen geschlechtlich übertragene krankheiten
KR1020017003161A KR100777896B1 (ko) 1998-09-11 1999-09-08 성인성질환에 대한 백신
SI9931008T SI1109574T1 (sl) 1998-09-11 1999-09-08 Cepivo proti spolno prenosljivim boleznim
HK01108911.8A HK1037978B (en) 1998-09-11 1999-09-08 Vaccine against sexually transmitted diseases
EP99969034A EP1109574B1 (en) 1998-09-11 1999-09-08 Vaccine against sexually transmitted diseases
TR200100948T TR200100948T2 (tr) 1998-09-11 1999-09-08 Cinsel yoldan bulaşan hastalıklara karşı aşı
IL14184399A IL141843A0 (en) 1998-09-11 1999-09-08 Vaccine against sexually transmitted diseases
PCT/EP1999/006623 WO2000015255A1 (en) 1998-09-11 1999-09-08 Vaccine against sexually transmitted diseases
ES99969034T ES2304068T3 (es) 1998-09-11 1999-09-08 Vacuna frente a enfermedades de transmision sexual.
JP2000569839A JP2002524532A (ja) 1998-09-11 1999-09-08 新規ワクチンおよび使用方法
CA 2343399 CA2343399C (en) 1998-09-11 1999-09-08 Method of vaccination against hsv in human females
CN99813127A CN1325311A (zh) 1998-09-11 1999-09-08 抗性传播疾病的疫苗
NZ51042599A NZ510425A (en) 1998-09-11 1999-09-08 Vaccine comprising glycoprotein D (gD2t) against herpes simplex virus (HSV)
CNA2007101469740A CN101130070A (zh) 1998-09-11 1999-09-08 抗性传播疾病的疫苗
PL346651A PL199545B1 (pl) 1998-09-11 1999-09-08 Zastosowanie glikoproteiny D HSV lub jej immunologicznego fragmentu i adiuwantu
AU59752/99A AU744989B2 (en) 1998-09-11 1999-09-08 Vaccine against sexually transmitted diseases
BR9913630A BR9913630A (pt) 1998-09-11 1999-09-08 Vacina contra doenças sexualmente transmitidas
PT99969034T PT1109574E (pt) 1998-09-11 1999-09-08 Vacina contra doenças sexualmente transmitidas
MYPI99003916A MY122216A (en) 1998-09-11 1999-09-09 New vaccine and method of use
ARP990104534 AR021798A1 (es) 1998-09-11 1999-09-09 Procedimiento para tratar mujeres que sufren o son susceptibles a enfermedades de transmision sexual y uso de antigenos derivados o asociados con patogenoscausantes de std, para preparar vacunas aplicables en dicho procedimiento.
CO99057608A CO5090882A1 (es) 1998-09-11 1999-09-10 Nueva vacuna y procedimiento de uso des transmitidas sexualmente
TW88115828A TWI225790B (en) 1998-09-11 1999-09-14 New vaccine and method of use
NO20011193A NO329522B1 (no) 1998-09-11 2001-03-08 Anvendelse av avkortet HSV-glykoprotein D for fremstilling av en vaksine til forebygging av genital herpes sykdom.
ZA200101987A ZA200101987B (en) 1998-09-11 2001-03-09 Vaccine against sexually transmitted diseases.
US10/760,938 US20040151734A1 (en) 1998-09-11 2004-01-20 Vaccine and method of use
US11/158,652 US20050238659A1 (en) 1998-09-11 2005-06-22 Vaccine and method of use
CY081100643T CY1108147T1 (el) 1998-09-11 2008-06-18 Εμβολιο κατα των σεξουαλικως μεταδιδομενων νοσων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9819898A GB9819898D0 (en) 1998-09-11 1998-09-11 New vaccine and method of use

Publications (1)

Publication Number Publication Date
GB9819898D0 true GB9819898D0 (en) 1998-11-04

Family

ID=10838766

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9819898A Ceased GB9819898D0 (en) 1998-09-11 1998-09-11 New vaccine and method of use

Country Status (28)

Country Link
EP (1) EP1109574B1 (https=)
JP (1) JP2002524532A (https=)
KR (1) KR100777896B1 (https=)
CN (2) CN1325311A (https=)
AR (1) AR021798A1 (https=)
AT (1) ATE392214T1 (https=)
AU (1) AU744989B2 (https=)
BR (1) BR9913630A (https=)
CA (1) CA2343399C (https=)
CO (1) CO5090882A1 (https=)
CY (1) CY1108147T1 (https=)
CZ (1) CZ302808B6 (https=)
DE (1) DE69938555T2 (https=)
DK (1) DK1109574T3 (https=)
ES (1) ES2304068T3 (https=)
GB (1) GB9819898D0 (https=)
HU (1) HUP0104297A3 (https=)
IL (1) IL141843A0 (https=)
MY (1) MY122216A (https=)
NO (1) NO329522B1 (https=)
NZ (1) NZ510425A (https=)
PL (1) PL199545B1 (https=)
PT (1) PT1109574E (https=)
SI (1) SI1109574T1 (https=)
TR (1) TR200100948T2 (https=)
TW (1) TWI225790B (https=)
WO (1) WO2000015255A1 (https=)
ZA (1) ZA200101987B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69935606T9 (de) 1998-10-16 2021-03-11 Glaxosmithkline Biologicals S.A. Adjuvanzsysteme und impfstoffe
GB9921146D0 (en) 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
CA2630220C (en) 2005-11-22 2020-10-13 Doris Coit Norovirus and sapovirus antigens
US20090317421A1 (en) 2006-01-18 2009-12-24 Dominique Missiakas Compositions and methods related to staphylococcal bacterium proteins
CA2699513C (en) 2007-09-12 2018-03-13 Novartis Ag Gas57 mutant antigens and gas57 antibodies
GB0818453D0 (en) 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
WO2011008400A2 (en) 2009-06-16 2011-01-20 Novartis Ag High-throughput complement-mediated antibody-dependent and opsonic bactericidal assays
WO2011026111A1 (en) 2009-08-31 2011-03-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Oral delivery of a vaccine to the large intestine to induce mucosal immunity
AU2011237393B2 (en) 2010-04-08 2015-01-22 University Of Pittsburgh - Of The Commonwealth System Of Higher Education B-cell antigen presenting cell assay
KR20130121699A (ko) 2010-05-28 2013-11-06 테트리스 온라인, 인코포레이티드 상호작용 혼성 비동기 컴퓨터 게임 기반구조
CA2843854A1 (en) 2011-07-01 2013-01-10 The Regents Of The University Of California Herpes virus vaccine and methods of use
US11071745B2 (en) 2014-07-07 2021-07-27 Elian Llc Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
JP7525976B2 (ja) * 2014-07-07 2024-07-31 エリアン リミテッド ライアビリティ カンパニー ウイルス予防治療方法及び曝露前予防キット
BR112018017141A2 (pt) 2016-02-22 2019-01-02 Boehringer Ingelheim Vetmedica Gmbh método para a imobilização de biomoléculas
WO2020086408A1 (en) 2018-10-26 2020-04-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A high-yield perfusion-based transient gene expression bioprocess

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
ATE157882T1 (de) * 1993-03-23 1997-09-15 Smithkline Beecham Biolog 3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
GB9506863D0 (en) * 1995-04-03 1995-05-24 Smithkline Beecham Biolog Vaccines

Also Published As

Publication number Publication date
HK1037978A1 (en) 2002-03-01
CZ2001887A3 (cs) 2001-10-17
EP1109574B1 (en) 2008-04-16
HUP0104297A3 (en) 2004-10-28
MY122216A (en) 2006-03-31
PL346651A1 (en) 2002-02-25
CA2343399A1 (en) 2000-03-23
TWI225790B (en) 2005-01-01
DK1109574T3 (da) 2008-06-30
DE69938555D1 (de) 2008-05-29
BR9913630A (pt) 2001-05-22
NZ510425A (en) 2003-04-29
PL199545B1 (pl) 2008-09-30
IL141843A0 (en) 2002-03-10
CZ302808B6 (cs) 2011-11-23
ES2304068T3 (es) 2008-09-01
PT1109574E (pt) 2008-06-12
AU744989B2 (en) 2002-03-07
KR100777896B1 (ko) 2007-11-27
KR20010075049A (ko) 2001-08-09
NO329522B1 (no) 2010-11-01
EP1109574A1 (en) 2001-06-27
NO20011193L (no) 2001-05-09
AU5975299A (en) 2000-04-03
CA2343399C (en) 2010-08-03
ZA200101987B (en) 2002-05-09
DE69938555T2 (de) 2009-06-10
ATE392214T1 (de) 2008-05-15
TR200100948T2 (tr) 2001-07-23
SI1109574T1 (sl) 2008-08-31
JP2002524532A (ja) 2002-08-06
WO2000015255A1 (en) 2000-03-23
CY1108147T1 (el) 2014-02-12
AR021798A1 (es) 2002-08-07
CN1325311A (zh) 2001-12-05
CN101130070A (zh) 2008-02-27
HUP0104297A2 (hu) 2002-03-28
CO5090882A1 (es) 2001-10-30
NO20011193D0 (no) 2001-03-08

Similar Documents

Publication Publication Date Title
GB2374100B (en) Underreamer and method of use
PL350822A1 (en) Disposable wiper-cloth and method of making same
ZA981866B (en) Additive preparation and method of use thereof
AP2000001783A0 (en) Disinfectant and method of making
PL318128A1 (en) Polymer-polyol and method of obtaining polymer-polyols
EP1183062A4 (en) ARTIFICIAL BREATHING DEVICE AND METHOD OF USE
GB9929560D0 (en) Insert and method of manufacture thereof
PL350826A1 (en) Disposable wiper-cloth and method of making same
IL148247A0 (en) A vaccine composition and method of using the same
AP2001002080A0 (en) Pilveriser and method of pulverising
GB9819898D0 (en) New vaccine and method of use
EP1069901A4 (en) CALCILYTIC COMPOUNDS AND THEIR USE
GB2338014B (en) Novel drilling device and method of use
GB2346823B (en) Reamer and method of using the same
EP1086215A4 (en) PREPARATION AND USE OF HIGHER VACCINES
GB0006334D0 (en) Template and method of use thereof
GB9819900D0 (en) New vaccine and method of use
GB9819899D0 (en) New vaccine and method of use
GB9910550D0 (en) Apparatus and method of recirulating electrodeionisation
GB9822491D0 (en) Hairdressing device and method of use
PL342185A1 (en) Modified psilium and method of obtaining same
PL326573A1 (en) Novel paragene and method of obtaining same
GB9802295D0 (en) Apparatus and methods of use
HU9400634D0 (en) Vaccine and diagnosticum against parvovirosis of gooses and barbari duks
PL332356A1 (en) Biopreparation and method of obtaining same

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)